Age-related cholesterol and colorectal cancer progression: Validating squalene epoxidase for high-risk cases.

Autor: Jun SY; Rare Disease Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea.; Functional Genomics, University of Science and Technology, Daejeon, Korea.; Department of Cancer Biology, Cancer Center and Beckman Research Institute, City of Hope, Duarte, California, USA., Yoon HR; Immunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea., Yoon JY; Rare Disease Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea., Lee JJ; Rare Disease Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea., Kim JY; College of Medicine, Chungnam National University, Daejeon, Korea., Kim JM; College of Medicine, Chungnam National University, Daejeon, Korea., Kim NS; Rare Disease Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea.; Functional Genomics, University of Science and Technology, Daejeon, Korea.
Jazyk: angličtina
Zdroj: Aging cell [Aging Cell] 2024 Jul; Vol. 23 (7), pp. e14152. Date of Electronic Publication: 2024 Mar 22.
DOI: 10.1111/acel.14152
Abstrakt: As people age, the risk and progression of colorectal cancer (CRC), along with cholesterol levels, tend to increase. Nevertheless, epidemiological studies on serum lipids and CRC have produced conflicting results. We previously demonstrated that the reduction of squalene epoxidase (SQLE) due to accumulated cholesterol within cells accelerates CRC progression through the activation of the β-catenin pathway. This study aimed to investigate the mechanism by which age-related cholesterol accumulation within tissue accelerates CRC progression and to assess the clinical significance of SQLE in older individuals with elevated CRC risk. Using machine learning-based digital image analysis with fluorescence-immunohistochemistry, we assessed SQLE, GSK3β pS9 (GSK3β activity inhibition through serine 9 phosphorylation at GSK3β), p53 wild-type (p53 WT ), and p53 mutant (p53 MT ) levels in CRC tissues. Our analysis revealed a significant reduction in SQLE, p53 WT , and p53 MT and increase in GSK3β pS9 levels, all associated with the substantial accumulation of intra-tissue cholesterol in aged CRCs. Cox analysis underscored the significant influence of SQLE on overall survival and progression-free survival in grade 2-3 CRC patients aged over 50. SQLE and GSK3β pS9 consistently exhibited outstanding prognostic and diagnostic performance, particularly in older individuals. Furthermore, combining SQLE with p53 WT , p53 MT , and GSK3β pS9 demonstrated a robust diagnostic ability in the older population. In conclusion, we have identified that individuals aged over 50 face an increased risk of CRC progression due to aging-linked cholesterol accumulation within tissue and the subsequent reduction in SQLE levels. This study also provides valuable biomarkers, including SQLE and GSK3β pS9 , for older patients at elevated risk of CRC.
(© 2024 The Authors. Aging Cell published by Anatomical Society and John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje